a-ads798

Search This Blog

nativeadstera

aads970+250

729adst

798+90yilix

admetex 790+90

ad2bitcoin 728+90

zerads 728+90

aads468+60

zerads 468+60

admetex 460+60

aadsadaptabl

mob ylix

468+60asdster

468+60yilix

aads referal

ad2bit460+60

BACKGROUND: As an inhibitor of programmed death-1 (PD-1) protein, nivolumab has been shown to be effective in various cancers

 bstract

BACKGROUND: As an inhibitor of programmed death-1 (PD-1) protein, nivolumab has been shown to be effective in various cancers. We thus conducted this meta-analysis to compare the relative efficacy of nivolumab vs docetaxel-based chemotherapy as a second-line treatment for previously treated advanced non-small cell lung cancer (NSCLC).

METHODS: Relevant studies were identified through searches of databases and conference proceedings. Progression-free survival (PFS), overall survival (OS), drug responses, and adverse effects (AEs) were assessed as the primary endpoints.

RESULTS: After screening, we included six studies (949 patients) in the final analysis. Nivolumab showed better efficacy in terms of the PFS (hazard ratios [HR]: 0.70, P = 0.03), OS (HR: 0.70, P < 0.00001),< 0.00001)

CONCLUSIONS: For advanced NSCLC, nivolumab is a better therapy in terms of both anti-tumor efficacy and safety than docetaxel-based chemotherapy. More high-quality randomized controlled trials are needed to confirm these results.

PMID: 30628185 [PubMed - indexed for MEDLINE]

28 March 2020

11:12

Cancer & Heart (Cardio-Oncology, Cardiotoxicity, TEV)

Photo

Not included, change data exporting settings to download.

256×256, 6.0 KB

11:12

In reply to this message

pubmed: ctoall&ca or conall

Mitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy.


Related Articles

Mitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy.


Circ Res. 2020 Mar 27;126(7):926-941


Authors: Wallace KB, Sardão VA, Oliveira PJ


No comments:

Post a Comment

اكتب تعليق حول الموضوع

728x90'ads

Search This Blog